Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...

Objectives To compare the sensitivity of 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology (EULAR/ACR) classification criteria against 1997 ACR criteria for ...

At the forefront of discussions at ACR 2024 was the success of autologous CD19-directed CAR-T cell therapies in addressing B cell-mediated autoimmune diseases such as lupus and rheumatoid arthritis.

There was further good news for the lupus community at the ACR when Roche reported data from a phase 2 trial of its anti-CD20 antibody Gazyva/Gazyvaro (obinutuzumab) which showed the drug was ...

Most people with lupus have what’s called photosensitivity. That means you are sensitive to ultraviolet (UV) rays from sunlight and some types of indoor lighting. It’s important to understand how UV ...

View the latest Alsons Consolidated Resources Inc. (ACR) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Introduction In the type 1 and 2 SLE model, inflammation mediates type 1 manifestations, but its role in type 2 manifestations (eg, fatigue, myalgias, mood disturbance, cognitive dysfunction) is less ...

Objective Combination therapy with rituximab and belimumab is a novel treatment strategy for severe SLE and lupus nephritis. Phase II studies have shown promising results, although long-term data are ...